Curavit Clinical Research
Dave Hanaman is currently the President & Chief Commercial Officer at Curavit, a company revolutionizing clinical research. Dave also serves as an Operating Partner at Eden Capital, an Advisor at The Data Guild, an Investor at FOUR18 Intelligence Corp., and an Instructor at NOLS. Additionally, Dave is an Advisor at the University of Utah PIVOT Center and a former Investor at Evernym, Inc. Dave also has experience serving on the Board of Directors at Park City Angels and Liaison Technologies. With a BA in Political Science and International Relations from the University of California, Berkeley, Dave has a strong background in business, technology, and leadership.
This person is not in any offices
Curavit Clinical Research
Curavit is a “Virtual CRO" that designs and executes decentralized - or “virtual” - clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality.